Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients

Author： Hollebecque Antoine   Adenis Antoine   Taieb Sophie   Lebedinsky Claudia   Penel Nicolas  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.28, Iss.4, 2010-08, pp. : 529-530

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone

By Paz-Ares Luis  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 729-740

Springer Publishing Company

Access to resources Recommend Favorite

Recent Developments in Salvage Chemotherapy for Patients with Metastatic Soft Tissue Sarcoma

By Jörg Thomas Hartmann  

Drugs, Vol. 65, Iss. 2, 2005-01 ,pp. : 167-178

Adis International

Access to resources Recommend Favorite

Trabectedin: A Review of its Use in Soft Tissue Sarcoma and Ovarian Cancer

By Carter Natalie J.   Keam Susan J.  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 335-376

Adis International

Access to resources Recommend Favorite

Trabectedin: A Review of its Use in the Management of Soft Tissue Sarcoma and Ovarian Cancer

By Carter Natalie J.   Keam Susan J.  

Drugs, Vol. 67, Iss. 15, 2007-01 ,pp. : 2257-2276

Adis International

Access to resources Recommend Favorite

Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer

By Gullo Giuseppe   Bettio Daniela   Torri Valter   Masci Giovanna   Salvini Piermario   Santoro Armando  

Investigational New Drugs, Vol. 27, Iss. 2, 2009-04 ,pp. : 179-183

Springer Publishing Company

Access to resources Recommend Favorite